Warning! GuruFocus detected
5 Severe warning signs
with BXT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
BioNxt Solutions Inc
NAICS : 325412
SIC : 3799
ISIN : CA0909741062
Share Class Description:
FRA:BXT: Ordinary SharesCompare
Compare
Traded in other countries / regions
BNXT.CanadaBXT.GermanyBNXTF.USA IPO Date
2019-08-13Description
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -10.32 | |||||
| Debt-to-Equity | -0.76 | |||||
| Debt-to-EBITDA | -1.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -159.69 | |||||
| Beneish M-Score | -25.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.6 | |||||
| 3-Year EBITDA Growth Rate | 38.6 | |||||
| 3-Year EPS without NRI Growth Rate | 33.3 | |||||
| 3-Year FCF Growth Rate | 33.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.61 | |||||
| 9-Day RSI | 31.35 | |||||
| 14-Day RSI | 37.3 | |||||
| 3-1 Month Momentum % | 33.33 | |||||
| 6-1 Month Momentum % | 149.13 | |||||
| 12-1 Month Momentum % | 21.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.04 | |||||
| Quick Ratio | 0.04 | |||||
| Cash Ratio | 0.01 | |||||
| Days Sales Outstanding | 1545.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.9 | |||||
| Shareholder Yield % | -6.53 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -13007.14 | |||||
| Net Margin % | -15423.81 | |||||
| FCF Margin % | -7806.9 | |||||
| ROA % | -563.6 | |||||
| ROIC % | -101.77 | |||||
| 3-Year ROIIC % | -5165.96 | |||||
| ROC (Joel Greenblatt) % | -968.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 100.34 | |||||
| EV-to-EBIT | -9.44 | |||||
| EV-to-EBITDA | -9.64 | |||||
| EV-to-Revenue | 1235.55 | |||||
| EV-to-FCF | -16.7 | |||||
| Price-to-GF-Value | 1.69 | |||||
| Earnings Yield (Greenblatt) % | -10.59 | |||||
| FCF Yield % | -7.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioNxt Solutions Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.029 | ||
| EPS (TTM) (€) | -0.042 | ||
| Beta | 1.53 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.32 | ||
| Volatility % | 80.01 | ||
| 14-Day RSI | 37.3 | ||
| 14-Day ATR (€) | 0.036524 | ||
| 20-Day SMA (€) | 0.3573 | ||
| 12-1 Month Momentum % | 21.21 | ||
| 52-Week Range (€) | 0.106 - 0.417 | ||
| Shares Outstanding (Mil) | 113.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioNxt Solutions Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioNxt Solutions Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioNxt Solutions Inc Frequently Asked Questions
What is BioNxt Solutions Inc(FRA:BXT)'s stock price today?
The current price of FRA:BXT is €0.27. The 52 week high of FRA:BXT is €0.42 and 52 week low is €0.11.
When is next earnings date of BioNxt Solutions Inc(FRA:BXT)?
The next earnings date of BioNxt Solutions Inc(FRA:BXT) is .
Does BioNxt Solutions Inc(FRA:BXT) pay dividends? If so, how much?
BioNxt Solutions Inc(FRA:BXT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers